NCT00274586View on ClinicalTrials.gov

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Cerebrovascular Accident
Interventions
DRUG

Aggrenox® modified release capsules

DRUG

Aggrenox® modified release capsules matching placebo

Trial Locations (1)

105

Chang Gung Memorial Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00274586 - Headache Study to Compare Aggrenox Full Dose and Reduced Dose | Biotech Hunter | Biotech Hunter